Author:
Garcia-Carbonero Rocio,Salazar Ramon,Duran Ignacio,Osman-Garcia Ignacio,Paz-Ares Luis,Bozada Juan M.,Boni Valentina,Blanc Christine,Seymour Len,Beadle John,Alvis Simon,Champion Brian,Calvo Emiliano,Fisher Kerry
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy
Reference46 articles.
1. Seymour LW, Fisher KD. Oncolytic viruses: finally delivering. Br J Cancer. 2016;114:357–61.
2. Woller N, Gurlevik E, Ureche CI, Schumacher A, Kuhnel F. Oncolytic viruses as anticancer vaccines. Front Oncol. 2014;4:188.
3. Amgen Inc. Food and Drug Administration (FDA). US prescribing information. IMLYGIC (talimogene laherparepvec). 2015. http://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM469575.pdf . Accessed 4 Nov 2016.
4. Amgen Inc. European Medicines Agency. Imlygic EPAR Product Information. 2016. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002771/WC500201079.pdf . Accessed 9 Dec 2016.
5. Bauzon M, Hermiston TW. Oncolytic viruses: the power of directed evolution. Adv Virol. 2012;2012:1–5.
Cited by
122 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献